Hawthorne Effect raises $20M with plans to disrupt the decentralized clinical trial space,

“Traditionally, before decentralized, traditionally clinical sites are engaged to conduct clinical trials on behalf of a sponsor,” Jodi Akin, CEO and founder …, “Traditionally, before decentralized, traditionally clinical sites are engaged to conduct clinical trials on behalf of a sponsor,” Jodi Akin, CEO and founder …, Read More

Scroll to Top